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I.  INTRODUCTION
In The Structure of Scientific Revolutions, Thomas Kuhn rejects the concept of
“development-by-accumulation,” which describes scientific advancement as
based on a progression of ideas, each incorporating all that precede it, and ulti-
mately yielding a new understanding.1  He views scientific revolutions as “non-
cumulative developmental episodes in which an older paradigm is replaced in
whole or in part by an incompatible new one.”2  Although Kuhn’s book ad-
dressed scientific revolutions, his concept of paradigm shifts has influenced
many different fields of thought, and can be applied to the area of HIV/AIDS
prevention and care.3
The delivery of publicly-funded health care is undergoing a paradigm shift.
Historically, Medicaid operated under national fee-for-service systems.  These
systems focused on acute, episodic interventions with reimbursements for pro-
viders’ fees that were defined for specific services.4  Currently, however, Medi-
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1. See THOMAS KUHN, THE STRUCTURE OF SCIENTIFIC REVOLUTIONS 2 (1996).
2. Id. at 92.
3. See Malcolm Gladwell, My Jaw Dropped, NEW YORKER, July 8, 1996, at 32, 32.
4. See David M. Eddy, Balancing Cost and Quality in Fee-for-Service Versus Managed Care,
HEALTH AFF., May-June 1997, at 162, 163.
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caid operates primarily under managed care plans.5  These plans consist of state-
associated delivery systems that focus on cost control and care management;
providers are paid a predetermined, or “capitated,” dollar amount per patient to
provide certain levels of care.6  This shift to capitated reimbursement necessarily
affects the methods that women, including those with HIV, use to access primary
health and specialty care.7
This Article addresses three issues of importance to the HIV/AIDS care of
women under Medicaid managed care systems: changes concerning access to
services women will face; how coordinated quality services will be delivered;
and whether reimbursement rates will be sufficient to cover the costs of care.
II.  THE PARADIGM SHIFT
This shift from fee-for-service care to managed care has been marked by
two changes, both of which may have significant implications for the health care
of women with HIV/AIDS.  First, Medicaid has been decentralized, moving
from a federally-driven system into a state-driven system.8  At the same time,
Medicaid has been disconnected from general public assistance.9  Second, a
growing number of states have opted for capitated managed care systems.
Three important statutes underlie the decentralization of Medicaid and its
separation from general public assistance.  The first is the Omnibus Budget Rec-
onciliation Act of 1981 (OBRA).10  OBRA provides the legal flexibility for states to
request permission to alter the required health care provisions for eligible indi-
viduals under publicly funded programs such as Medicaid.11  As a result, states
are able to expand coverage of eligible populations, alter benefits packages, and
introduce managed care systems.
The second is the Personal Responsibility and Work Opportunity Recon-
ciliation Act of 1996 (PRWORA).12  PRWORA abolished Aid to Families with De-
5. In 1993, there were 166 Medicaid managed care plans.  See Suzanne Felt-Lisk & Sara Yang,
Changes in Health Plans Serving Medicaid, 1993-1996, HEALTH AFF., Sept.-Oct. 1997, at 125, 128 ex.1.
By the end of 1996, there were 355 managed care plans serving 7.7 million clients in 35 states.  See id.
at 127.  In 1997, about 40% of all Medicaid beneficiaries were enrolled in managed care.  See Sara
Rosenbaum, A Look Inside Medicaid Managed Care: A Study of Medicaid Contracts Sheds Light on the
Program’s Transition to Managed Care, HEALTH AFF., July-Aug. 1997, at 266, 266.  By the end of 1998,
“half of all people enrolled in Medicaid programs are expected to be in managed care.”  HEALTH
RESOURCES & SERVS. ADMIN. ET AL., HIV CAPITATION RISK ADJUSTMENT: CONFERENCE REPORT 1
(1997) [hereinafter HIV CAPITATION RISK ADJUSTMENT].
6. For a discussion of the differences between fee-for-service care and Medicaid managed care,
see Eddy, supra note 4, at 165-70.
7. See generally CENTER FOR WOMEN POLICY STUDIES, MEDICAID MANAGED CARE: SERVING
WOMEN WITH HIV/AIDS (1997) (finding that women will be one of the groups most affected by shift
to managed care) [hereinafter CENTER FOR WOMEN POLICY STUDIES, MEDICAID MANAGED CARE].
8. See Kant Patel, Medicaid: Perspectives from the States, 7 J. HEALTH & SOC. POL’Y 1, 1-2, 7-17
(1996).
9. See id. at 1-2.
10. Pub. L. No. 97-35, 95 Stat. 357 (1981) (codified in scattered sections of 42 U.S.C.).
11. See 42 U.S.C. § 1396n (1994).
12. Pub. L. No. 104-193, 110 Stat. 2105 (codified as amended in scattered sections of 8 U.S.C.
and 42 U.S.C.).
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pendent Children (AFDC),13 created the Temporary Assistance for Needy Fami-
lies (TANF)14 block grant program, and gave states the authority to design their
own public assistance programs.15  This statute is significant for the effects it has
had on both the decentralization of Medicaid and its separation from general as-
sistance.  Under the old AFDC program, families that met the eligibility re-
quirements automatically received Medicaid assistance according to prescribed
federal regulations.16  Under the new TANF program, however, states are given
discretion to determine levels of entitlements for welfare recipients, as well as
eligibility requirements for receiving them.17  Because the TANF program does
not enroll recipients automatically in Medicaid as the AFDC program had, for-
mer AFDC program recipients may no longer be eligible for Medicaid assis-
tance.18  The reverse also may occur, as people may be eligible for medical assis-
tance but ineligible for the TANF program.19 
The third statute is the Balanced Budget Act of 1997 (BBA).20  The BBA out-
lines instances in which a state may implement a Medicaid managed care pro-
gram without first seeking a waiver from federal requirements.21  As a result,
states have additional flexibility to structure their management of covered health
care.22
The second change resulting from the shift from fee-for-service to managed
care is that a growing number of states have opted for capitated managed care
systems.  Under capitated managed care, providers receive a per-member per-
month fee, rather than a procedure-based or service-based reimbursement.23
Capitated fees cover expenditures associated with a prescribed package of bene-
13. The AFDC program was authorized in Title IV of the Social Security Act of 1935, Pub. L.
No. 74-271, 49 Stat. 620, 627-29 (42 U.S.C. §§ 601-676 (1994)).
14. Pub. L. No. 104-193, 110 Stat. 2105, 2112-13  (1996) (42 U.S.C.A. § 601 (West Supp. 1997)).
15. See 42 U.S.C.A. §§ 602, 603 (1997).
16. See 42 C.F.R. § 435.110(a) (1997).
17. See 42 C.F.R. § 430.0 (1997).
18. Another difference between the two programs involves funding limitations: while funding
for AFDC increased in response to increased demand, the funding for TANF is fixed.  See Greg J.
Duncan & Gretchen Caspary, Welfare Dynamics and the 1996 Welfare Reform, 11 NOTRE DAME J.L.
ETHICS & PUB. POL’Y 605, 608 (1997).  When states have to cut corners in order to manage their lim-
ited funds, see Ann Marie Rotondo, Helping Families Help Themselves: Using Child Support Enforcement
to Reform Our Welfare System, 33 CAL. W. L. REV. 281, 287 (1997), women with HIV/AIDS may feel
the pinch.
19. See Laurence Lavin, AIDS, Medicaid, and Women, 5 DUKE J. GENDER L. & POL’Y 193, 200-01
(1998) (describing the “de-linking” of Medicaid eligibility from eligibility for TANF and how it has
exacerbated already existing barriers to medical care).  Additional provisions of the law spell out
work requirements and payment limits for any state’s recipients.  See 42 U.S.C.A. § 1396u-1(b)(3)
(West Supp. 1997).
20. Pub. L. No. 105-33, 111 Stat. 251 (1997) (amending portions of Personal Responsibility and
Work Opportunity Reconciliation (Welfare Reform) Act, Pub. L. No. 104-193, 110 Stat. 2105 (1996)).
21. See id.
22. With the flexibility granted by the PRWORA and BBA, states could, among other things,
expand services such as primary care case management, modify eligibility requirements such as the
percentage above the poverty level at which individuals qualify for Medicaid, or mandate that
Medicaid participants enroll in managed care.
23. See HIV CAPITATION RISK ADJUSTMENT, supra note 5, at 1.
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fits for the client.24  To change from a Medicaid fee-for-service plan to a capitated
managed care plan, a state either must request a waiver under section 191525 or
section 111526 of the Social Security Act, or must meet the requirements of the
BBA.27  Under the BBA, a state must write beneficiary protections, develop qual-
ity assurance standards, and assure that timely payment requirements are in-
cluded in contracts.28  Upon either receiving a section 1915(b) waiver approval or
qualifying for an exemption, a state may mandate enrollment for eligible popu-
lations in managed care by county.29  A section 1115 waiver offers a state addi-
tional freedom to modify Medicaid requirements, including rules on benefits,
provider qualification and payment rules, and administrative requirements.30
As states institute a wide variety of managed care plans31 for TANF and
Supplemental Security Income (SSI)32 recipients, they must ensure that the per-
member payments are sufficient to cover the needs of HIV/AIDS patients, fifty-
three percent of whom are dependent on Medicaid.33  Additionally, each state’s
Medicaid plan must be monitored to ensure that HIV care, regardless of the
24. See MARIA K. TODD, THE MANAGED CARE CONTRACTING HANDBOOK: PLANNING AND
NEGOTIATING THE MANAGED CARE RELATIONSHIP 7-8 (1996).
25. See 42 U.S.C. § 1396n (1994).
26. See 42 U.S.C. § 1315(a) (1994).
27. See Pub. L. No. 105-33, 111 Stat. 251 (1997).  For descriptions of the section  1115 waiver  ap-
plication procedure, see Vernellia Randall et al., Section  1115  Medicaid  Waivers: Critiquing the State
Applications, 26 SETON HALL L. REV. 1069, 1073 n.22 (1996).
28. See Pub. L. No. 105-33, 111 Stat. 251 (1997); see also HCFA Urges States to Submit Draft Con-
tracts for Review Before Expanding Managed Care, 6 Health Care Pol’y (BNA) 7, 7-8 (Jan. 5, 1998).
29. See Pub. L. No. 105-33, 111 Stat. 251 (1997); see generally John Holahan et al., Insuring the Poor
Through Section 1115 Medicaid Waivers, HEALTH AFF., Spring 1995, at 199, 199-216 (analyzing five
state waiver demonstration programs under Section 1115).  For a listing of approved section 1915(b)
waivers from January 1, 1997 through March 31, 1997, see First Quarter 1997 Approved 1915(b) Waiv-
ers Report (last updated June 18, 1997) <http://www.hcfa.gov/medicaid/omc5.htm>.
30. See 42 U.S.C. § 1315 (1994); see also SARA ROSENBAUM ET AL., CENTER FOR HEALTH POLICY
RESEARCH, NEGOTIATING THE NEW HEALTH SYSTEM: A NATIONWIDE STUDY OF MEDICAID MANAGED
CARE CONTRACTS Part I.2. (Kay A. Johnson ed., 1997); Lavin supra note 19, at 203 n.95 (describing
specific waiver requests by Maine).
31. See Diane Rowland & Kristina Hanson, Medicaid: Moving to Managed Care, HEALTH AFF., Fall
1996, at 150, 150-52 (describing the dramatic increase in states’ use of managed care programs).
32. See 42 U.S.C.A. § 1381 (1994); see also Alison Barnes, The Policy and Politics of Community-
Based Long-Term Care, 19 NOVA L. REV. 487, 515 n.161 (1995) (noting that “[SSI] provides a guaran-
teed minimum income for individuals who are aged, blind, or disabled, who have insufficient work-
force participation to be eligible for [Social Security Disability Income].”).
33. See JEFFREY S. CROWLEY, NATIONAL ASS’N OF PEOPLE WITH AIDS, MAKING MEDICAID
MANAGED CARE WORK: AN ACTION PLAN FOR PEOPLE LIVING WITH HIV 5 (1997) [hereinafter AN
ACTION PLAN].  In addition, 90% of HIV-positive children are dependent upon Medicaid.  See id.
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variation under which it is provided, meets or exceeds treatment guidelines for
women.34
III.  WOMEN LIVING WITH HIV/AIDS
HIV/AIDS is a growing concern for and among women in the United
States.35  Recent surveillance data suggest that between one-third and one-half of
all HIV testing is performed on women between the ages of fifteen and forty-
four.36  According to the data, between 120,000 and 160,000 women are living
with HIV in the United States;37 in 1996 alone, 13,820 adult or adolescent women
were diagnosed with AIDS,38 more than seventy-nine percent of whom were
women of color.39  HIV/AIDS has emerged as a major health concern, particu-
34. See, e.g., Panel of Clinical Practices for the Treatment of HIV Infection, U.S. Dep’t of Health
& Human Servs., Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Ado-
lescents (1997) (providing recommendations for the clinical treatment of HIV using antiretroviral
therapies including the recently introduced protease inhibitors and non-nucleoside reverse tran-
scriptase inhibitors) (on file with the Duke Journal of Gender Law & Policy).  The Department of
Health and Human Services issued a request for comments on these guidelines in June 1996.  See
Availability of Report of NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines
for the Use of Antiretroviral Agents in HIV-Infected Adults, 62 Fed. Reg. 33,417 (1997).  Both of
these sources also can be accessed at <http://www.hivatis.org/upguidaa.html>.
35. See generally Risa Denenberg, The Community: Mobilizing and Accessing Resources and Services,
in WOMEN, CHILDREN, AND HIV/AIDS 251, 251 (Felissa L. Cohen & Jerry D. Durham eds., 1993);
Susan Cu-Uvin et al., Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syn-
drome Among North American Women, 101 AM. J. MED. 316 (1996) (describing the rapid increase in the
incidence of AIDS among women).  Women now represent almost 20% of the AIDS cases in the
United States, see Centers for Disease Control & Prevention, U.S. Dep’t of Health & Human Servs.,
Update: Trends in Aids Incidence—United States, 1996, 46 MORBIDITY  & MORTALITY WKLY. REP. 861,
865 tbl.3 (1997), a proportion that has doubled since 1990, see Tedd V. Ellerbrock et al., Epidemiology
of Women with AIDS in the United States, 1981 through 1990: A Comparison with Heterosexual Men with
AIDS, 265 JAMA 2971, 2972 (1991) (noting that in 1990 women represented approximately 10% of
the reported adult AIDS cases).
36. See Tracey E. Wilson et al., HIV-Antibody Testing: Beliefs Affecting the Consistency Between
Women’s Behavioral Intentions and Behavior, 26 J. APPLIED PSYCHOL. 1734, 1735 (1996).  Many women,
however, do not discover that they are infected with the virus until they arrive at an emergency
room, a physician’s office, or a hospital for care.  See Pascale M. Wortley et al., HIV Testing Patterns:
Where, Why, and When Were Persons with AIDS Tested for HIV?, 9 AIDS 487, 490 (1995) (finding that
many persons diagnosed with AIDS between 1990 and 1992 were not tested until they were admit-
ted to an acute care facility).
37. See John M. Karon et al., Prevalence of HIV Infection in the United States, 1984 to 1992, 267
JAMA 126, 128 tbl.1 (1996).  Like other sexually transmitted diseases, HIV infection transmits more
easily to women than to men.  See Timothy P. Flanigan et al., Update of HIV and AIDS in North Amer-
ica, 79 MED. & HEALTH, RHODE ISLAND 180, 180 (1996).  While the most common mode of HIV
transmission among women remains intravenous drug use, recent data from states with confidential
HIV infection reporting indicate that heterosexual contact has surpassed intravenous drug use as the
most frequent source of infection for women.  See CENTERS FOR DISEASE CONTROL & PREVENTION,
U.S. DEP’T OF HEALTH & HUMAN SERVS., NO. 2, HIV/AIDS SURVEILLANCE REPORT 12 tbl.5 (1996)
[hereinafter HIV/AIDS SURVEILLANCE REPORT 1996]; see also Pascale M. Wortley & Patricia L.
Fleming, AIDS in Women in the United States: Recent Trends, 278 JAMA 911, 912 (1997).  These data
are representative of only 29 states with confidential HIV infection reporting.  See HIV/AIDS
SURVEILLANCE REPORT 1996, supra, at 35 tbl.27.
38. See HIV/AIDS SURVEILLANCE REPORT 1996, supra note 37, at 10 tbl.3.
39. See id. at 12 tbl.5.  Moreover, of those females diagnosed with AIDS through December
1996, over 70% were under the age of forty.  See id. at 16 tbl.9.
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larly among young African-American and Latina women40—women who histori-
cally have constituted healthy and, therefore, low-cost populations when com-
pared to the Medicaid population as a whole.
Despite the high number of women with HIV/AIDS, the clinical care that
women receive has been developed through research conducted primarily with
men.41  However, significant differences exist in the health care needs of women
based on gender, behavior, modes of transmission, and gynecological condi-
tions.42  For example, certain opportunistic infections occur more frequently in
women than in men.  Moreover, gynecological conditions associated with HIV
disease can complicate the treatment of women.43  Pregnancy also raises unique
complications for HIV care;44 the introduction of effective treatments, such as zi-
dovudine to prevent vertical transmission of HIV from mother to fetus, requires
early detection of the disease, more frequent medical visits, and an increased use
of pharmaceuticals.45
Furthermore, early studies found that HIV disease progressed more quickly
in women than in men from the time of diagnosis;46 more recent clinical research
has offered findings that indicate that gender differences in disease progression
40. See Cu-Uvin et al., supra note 35, at 316 (finding that almost 75% of women with AIDS in the
United States are African-American or Latina, although they comprise only 20% of American
women).
41. See Catherine A. Hankins & Margaret A. Handley,  HIV Disease and AIDS in Women: Current
Knowledge and a Research Agenda 5 J. ACQUIRED IMMUNE DEFICIENCY SYNDROMES 957, 957-58 (1992);
HEALTH RESOURCES & SERVS. ADMIN., U.S. DEP’T HEALTH & HUMAN SERVS., HIV/AIDS WORK
GROUP ON HEALTH CARE ACCESS ISSUES FOR WOMEN 63 app. D (1993) [hereinafter DHHS HIV/AIDS
WORK GROUP]; R. Ancello-Park & I. De Vincenzi, Epidemiology and Natural History of HIV/AIDS in
Women, in HIV INFECTION IN WOMEN 1, 8 (Margaret A. Johnson & Frank D. Johnstone eds., 1993).
42. See Marge Berer & Sunanda Ray, HIV/AIDS-related Illnesses, Effects on Women’s Health,
Treatment and Care, in WOMEN AND HIV/AIDS: AN INTERNATIONAL RESOURCE BOOK 14, 15-31
(Marge Berer & Sunanda Ray eds., 1993); Jeanette R. Ickovics & Judith Rodin, Women and AIDS in the
United States: Epidemiology, Natural History, and Mediating Mechanisms, 11 HEALTH PSYCHOL. 1, 1-16
(1992).
43. See Cu-Uvin et al., supra note 35, at 318-20.  For example, the occurrence of candida espo-
hagitis and extensive chronic ulcerative disease secondary to herpes simplex are gender related.  See
id. at 318 tbl.I, 319.
44. See DHHS HIV/AIDS WORK GROUP, supra note 41, at 13-16.
45. See Edward M. Connor et al., Reduction of Maternal-Infant Transmission of Human Immunodefi-
ciency Virus Type 1 with Zidovudine Treatment, 331 NEW ENG. J. MED. 1173, 1178-79 (1994) (describing
decreased risk of vertical transmission in pregnant women taking zidovudine); Josephine A. Mausk-
opf et al., Economic Impact of Treatment of HIV-Positive Pregnant Women and Their Newborns with Zido-
vudine, 276 JAMA 132, 136-38 (1996); cf. Evans McMillion, Note, The Case Against Mandatory HIV
Testing of Pregnant Women: The Legal and Public Policy Implications, 5 DUKE J. GENDER L. & POL’Y 227,
228-44 (1998) (arguing against the mandatory HIV-testing of pregnant women).
46. See Ann B. Williams, The Epidemiology, Clinical Manifestations and Health-Maintenance Needs of
Women Infected with HIV, NURSE PRACTITIONER, May 1992, at 27, 32-34.
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may result from women’s lack of access to HIV care.47  This may cause significant
differences in how HIV affects women and men, as women repeatedly report
difficulties in accessing services,48 ranging from a lack of knowledge of available
services to the lack of resources to secure them.49
Women with HIV disease face numerous obstacles to the procurement of
essential services.50  Because HIV/AIDS correlates with poverty,51 and women
are more likely than men to be poor, uninsured, or underinsured,52 women are
more likely to receive insufficient medical care.53  Medical appointments may
leave patients waiting for hours, yet result only in a schedule of tests and a hand-
ful of unaffordable prescriptions.54  Moreover, if an infected woman also is re-
sponsible for an infected child, the medical needs of both must be met.55  The
medical setting in which a mother receives care, however, may not be structured
to accommodate a mother and child together.56  Language and cultural differ-
ences can complicate further the struggle many women experience in acquiring
47. See Ancello-Park & De Vincenzi, supra note 41; Howard L. Minkoff & Jack A. DeHovitz,
Care of Women Infected with the Human Immunodeficiency Virus, 266 JAMA 2253, 2253-58 (1991); Rich-
ard Rothenberg et al., Survival with the Acquired Immunodeficiency Syndrome, 317 NEW ENG. J. MED.
1297, 1300 tbl.2 (1987).  Similarly, the use of new pharmaceuticals such as protease inhibitors re-
quires routine and frequent access to medical services.  See Steven G. Deeks et al., HIV-1 Protease In-
hibitors: A Review for Clinicians, 277 JAMA 145, 151-52 (1997).  But see Beverly E. Sha et al., HIV Infec-
tion in Women: An Observational Study of Clinical Characteristics, Disease Progression, and Survival for a
Cohort of Women in Chicago,  8 J. ACQUIRED IMMUNE DEFICIENCY SYNDROMES & HUMAN
RETROVIROLOGY 486, 494 (1995) (noting that in their study, insurance status, as an indicator of access
to health care, did not influence the survival time of women with AIDS).
48. See, e.g., CENTER FOR WOMEN POLICY STUDIES, “WE KNOW WE’RE NOT ALONE”: THE VOICES
OF WOMEN LIVING WITH HIV/AIDS IN THE METROPOLITAN DC AREA: A CONTENT ANALYSIS OF FOCUS
GROUPS WITH AFRICAN AMERICAN, LATINA, AND WHITE WOMEN 4-24, 39-52 (1997) (discussing the
difficulties HIV-positive women face in accessing health care and housing) (unpublished manuscript
on file with the Duke Journal of Gender Law and Policy).
49. See DHHS HIV/AIDS WORK GROUP, supra note 41, at 5-20.
50. See Kathleen A. Ethier et al., For Whose Benefit? Women and AIDS Public Policy, in WOMEN
AND AIDS: COPING AND CARING 207, 216-19 (Ann O’Leary & Loretta Sweet Jemmott eds., 1996); see
generally Greg Rubin, Confronting Obstacles, in WOMEN, POVERTY, AND AIDS: SEX, DRUGS, AND
STRUCTURAL VIOLENCE 279, 279-98 (Paul Farmer et al. eds., 1996); Jeffrey Selbin & Mark Del Monte,
A Waiting Room of Their Own: The Family Care Network as a Model for Providing Gender-Specific Legal
Services to Women with HIV, 5 DUKE J. GENDER L. & POL’Y 103, 116-19 (1998).
51. See Ethier et al., supra note 50, at 216.
52. See id.
53. See id.  One study found that more women than men received Medicaid, and that this was a
critical factor in compromising women’s access to care and the quality of that care.  See id. at 218.
54. See Gloria Weissman et al., Women Living with Drug Abuse and HIV Disease: Drug Abuse
Treatment Access and Secondary Prevention Issues, 27 J. PSYCHOACTIVE DRUGS 401, 402-03 (1995).
55. See Patricia Antoniello, The Voices of Women with HIV Infection, in PRIMARY CARE OF WOMEN
AND CHILDREN WITH HIV INFECTION: A MULTIDISCIPLINARY APPROACH 1, 3-4 ( Patricia Kelly et al.
eds., 1995).  Even infants who are not infected with HIV require medical care and general care, pos-
ing another problem for infected mothers.  See id.
56. See Darlene Shelton et al.,  Medical Adherence Among Prenatal HIV Seropositive, African Ameri-
can Women: Family Issues, 11 FAM. SYS. MED. 343, 348 (1993) (describing the difficulties of medical
adherence for a woman who must take care of her small children).
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care.57  In addition to these obstacles to basic care, women infected with HIV also
may have additional needs such as HIV education, case management,58 and the
provision of social services such as housing, transportation, public assistance,
psychological health services, support groups, nutrition assistance, pastoral care,
child care, and legal services.59
An additional layer of complexity arises from the fact that HIV is rarely an
isolated problem for infected women.  HIV-positive women come from diverse
social, cultural, and economic backgrounds, and many struggle with domestic
violence, poverty, homelessness, or inadequate housing.60  Furthermore, because
a large percentage of identified HIV-positive women are intravenous drug users,
many women also may need drug treatment and mental health services.61  These
complex health and social needs of women with HIV must be considered as the
states determine their Medicaid reimbursement fees for managed care plans and
define the eligible populations for Medicaid coverage.
57. See generally Johanna Daily et al., Women and HIV Infection: A Different Disease?, in WOMEN,
POVERTY, AND AIDS, supra note 50, at 125, 125-44 (illustrating, through the stories of two women,
how women with language and cultural differences require medical services that build in specific
language and cultural support); see also Dawn F. Smith & Janet S. Moore, Epidemiology, Manifesta-
tions, and Treatment of HIV Infection in Women, in WOMEN AND AIDS, supra note 50, at 1, 18 (noting
the additional difficulties faced by “non-English-speaking, low-literacy, and drug-using women” in
receiving appropriate HIV treatment).
58. One source has defined case management as follows:
A patient-centered process which has been used to augment and coordinate existing care
systems.  Its goals are to access health and mental health care for patients; provide or ob-
tain social support services; and, empower patients, family members, and significant oth-
ers.  The means of achieving these goals include providing education; creating connections
between careseekers and caregivers; promoting active participation of the patient, family,
and significant others in developing care plans; and acknowledging and complementing
the important support given by family and significant others.
CENTER FOR WOMEN POLICY STUDIES, MEDICAID MANAGED CARE, supra note 7, at 13 (citation omit-
ted).
59. See Mardge H. Cohen & Patricia Kelly, HIV Disease in the Primary Care Setting, in PRIMARY
CARE OF WOMEN AND CHILDREN WITH HIV INFECTION, supra note 55, at 9, 9-18; see also CENTER FOR
WOMEN POLICY STUDIES, MEDICAID MANAGED CARE, supra note 7, at 9 (“Of particular importance in
assuring access to medical care are ‘enabling services,’ such as transportation and case management
(coordination of care) . . . .”); cf. DARLENE SHELTON ET AL., U.S. DEP’T OF HEALTH & HUMAN SERVS.,
HIV/AIDS HEALTH CARE, UTILIZATION & MEDICAL ADHERENCE ISSUES AMONG HIV SEROPOSITIVE
AFRICAN AMERICAN WOMEN IN MIAMI: THE ROLE OF THE FAMILY AND THE EXTENDED KINSHIP
NETWORK 23 (1993) (exploring influences on health care utilization, and reporting the importance of
access to transportation and child care, family support, and possible pregnancy or substance abuse);
Selbin & Del Monte, supra note 50, at 116-19.
60. See Carol Levine & Machelle Harris Allen, Social Interventions in the Care of Human Immu-
nodeficiency Virus (HIV)-Infected Pregnant Women, 19 SEMINARS IN PERINATOLOGY 323, 324 (1995).
61. See HIV/AIDS SURVEILLANCE REPORT 1996, supra note 37, at 12 tbl.5 (noting that 45% of
women reported with AIDS through 1996 were intravenous drug users); see also Weissman et al.,
supra note 54, at 401-02.
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IV.  CAN RESEARCH HELP?
States’ experience with Medicaid managed care for elderly and disabled
beneficiaries is not extensive.62  As of 1996, only five states had more than one
year of experience with mandated Medicaid managed care systems for individu-
als with disabilities: Arizona, Oregon, Tennessee, Utah, and Virginia.63  Another
eleven states voluntarily had operated similar programs for a year or more, but
fewer than twenty percent of the eligible Medicaid populations were enrolled.64
Given the few states involved and the limited coverage that exists for indi-
viduals with disabilities in those states, there is little information available on
managed care plans for women with HIV.65  Research on the effects of managed
care on disabled populations with private insurance, however, can provide some
insight as to what can be expected for the Medicaid-funded care of women with
HIV.  A study of 12,997 health maintenance organization (HMO) patients suf-
fering from at least one of five diseases—arthritis, asthma, epigastric pain/ulcer,
hypertension, or otitis media—identified a strong correlation between the sever-
ity of illness and the frequency of health resource utilization.66  Especially appli-
cable to the care of women with HIV is the finding that limitations on reim-
bursement for pharmaceuticals were associated with increased numbers of
ambulatory and emergency room visits, and a greater number of hospitaliza-
tions.67  This finding has significant implications for the future health care of
women with HIV/AIDS.  Because it is expected that pharmaceuticals will be-
come one of the more expensive facets of HIV care,68 managed care plans may
consider limiting coverage for HIV pharmaceuticals and associated tests.  If
women with HIV/AIDS anticipate that the costs of pharmaceuticals might ex-
ceed reimbursement levels, they will be likely to reduce their use of such phar-
maceuticals and, therefore, suffer a gap in care.69  While managed care plans may
save money in the short run, in the long run they would lose money, as such a
strategy would tend to increase opportunistic infections, as well as overall medi-
cal costs.
Another potential disadvantage of managed care may surface if health
plans receive the same reimbursement rates for both sick and healthy clients.
62. See CENTER FOR WOMEN POLICY STUDIES, MEDICAID MANAGED CARE, supra note 7, at 8; U.S.
GEN. ACCOUNTING OFFICE, MEDICAID MANAGED CARE: SERVING THE DISABLED CHALLENGES STATE
PROGRAMS 4-5, 24-25 (1996).  While only a few states have long-term experience with Medicaid man-
aged care, Medicaid managed care has become very widely-used in recent years.  See Sara Rosen-
baum, A Look Inside Medicaid Managed Care: A Study of Medicaid Contracts Sheds Light on the Program’s
Transition to Managed Care, HEALTH AFF., July-Aug 1997, at 266, 266 (noting that in 1997, nearly 40%
of all Medicaid beneficiaries were enrolled in managed care).
63. See U.S. GEN. ACCOUNTING OFFICE, supra note 62, at 4, 24-25.
64. See id.
65. See CENTER FOR WOMEN POLICY STUDIES, MEDICAID MANAGED CARE, supra note 7, at 8-9.
66. See Susan D. Horn et al., Intended and Unintended Consequences of HMO Cost-Containment
Strategies: Results from the Managed Care Outcomes Project, 2 AM. J. MANAGED CARE 253, 259-60 (1996).
67. See id. at 259.
68. See CALIFORNIA DEP’T OF HEALTH SERVS., MEDI-CAL STUDIES, NO. 5, AIDS: DEMOGRAPHICS
AND EXPENDITURES FOR PERSONS WITH AIDS 1980-94 18, 19 tbl.10, 21 tbl.11 (1996).
69. Cf. Richard D. Moore & John G. Bartlett, Combination Antiretroviral Therapy in HIV Infection:
An Economic Perspective, 10 PHARMACOECONOMICS 109 (1996) (finding combination drug therapy to
be superior to monotherapy, and associated with a three-year increase in average lifespan).
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These plans will suffer financially if they enroll large numbers of HIV-positive
clients due to the high costs of their care.70  Research shows that in managed care
systems, both risk adjustment for HIV/AIDS and the use of HIV/AIDS medical
specialists as primary care physicians71 can assist in increasing access to quality
care for women.72  Risk adjustment procedures base capitation rates on the in-
sured’s individual health status and recent health care expenditures.73  This tech-
nique can be beneficial especially for people with chronic illnesses such as
HIV/AIDS, whose patterns of health care expenditures are more predictable
than those of the general population.74  Risk adjustment methods, therefore, can
assure that providers receive adequate per-member per-month reimbursement
for care.75  Additionally, access to specialists for primary care assures appropriate
treatment, which can prevent costly hospitalizations and opportunistic infec-
tions.
Additional studies have found that preventive and screening services are
provided more frequently to clients in HMOs than to those in fee-for-service
programs.76  While screening for HIV/AIDS was not included in the studies,77
Medicaid managed care may be able to identify HIV-positive women more
quickly by providing earlier testing, diagnosis, and linkages to treatment.
The Ryan White Comprehensive AIDS Resources Emergency (CARE) Act’s
Special Projects of National Significance (SPNS) Program78 is testing models of
capitated care to examine the tension between HIV health care delivery under
Medicaid managed care and fee-for-service plans, and to assess the possibilities
for delivering appropriate care to women with HIV/AIDS.  Six individual proj-
ects are examining the provision of managed HIV/AIDS services in different
70. See William J. Aseltyne et al., HIV Disease and Managed Care: An Overview, 8 J. ACQUIRED
IMMUNE DEFICIENCY SYNDROMES & HUMAN RETROVIROLOGY S11, S19-S20 (Supp. 1 1995).
71. Research has shown that physicians with specialized HIV/AIDS knowledge are more likely
than other practitioners to prescribe appropriate pharmaceuticals and provide state-of-the-art care.
See Mari M. Kitahata et al., Physicians’ Experience with the Acquired Immunodeficiency Syndrome as a
Factor in Patients’ Survival, 334 NEW ENG. J. MED. 701, 704-05 (1996).
72. See generally HIV CAPITATION RISK ADJUSTMENT, supra note 5.  An example of a successful
risk adjustment policy is Maryland’s Medicaid managed care program, HealthChoice, which has
developed a capitated model based on these two methods.  See id. at 20.  Maryland’s Department of
Health and Public Hygiene has agreed to supplemental payments for HIV care.  See id.  In addition,
Hopkins AIDS-Medicaid Capitated Care HMO at Johns Hopkins University will provide AIDS care
to Medicaid recipients.  See LAWRENCE BARTLETT & PATRICIA RUTH HITZ, KAISER FAMILY FOUND.,
DELIVERING HIV CARE IN A MANAGED CARE ENVIRONMENT: ISSUES AND STRATEGIES (1996).  Moreo-
ver, to ensure the solvency of the plan, the new, high-cost AIDS medications are excluded from the
capitation arrangement and paid for on a fee-for-service basis.  See HIV CAPITATION RISK AD-
JUSTMENT, supra note 5, at 21.
73. See HIV CAPITATION RISK ADJUSTMENT, supra note 5, at 3.
74. See id.
75. See id.; TONY DREYFUS ET AL., KAISER FAMILY FOUND., USING PAYMENT TO PROMOTE BETTER
MEDICAID MANAGED CARE FOR PEOPLE WITH AIDS 4 (1997).
76. See Amy B. Bernstein, Women’s Health in HMOs: What We Know and What We Need to Find
Out, 6 WOMEN’S HEALTH ISSUES 51, 55-58 (1996).
77. See generally id. at 51-59.
78. See 42 U.S.C.A. § 300ff-101 (West Supp. 1997).  The SPNS Program is authorized under Part
F of the CARE Act to support the development and evaluation of innovative and replicable models
for delivering health and support services to people with HIV.  See id.
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arenas, including community-based settings, university-based medical center
settings, and community health center settings.79  Each health care project is ei-
ther fully or partially-capitated.80  To date, only one project evaluation, that of the
Visiting Nurses Association of Los Angeles, a not-for-profit home care agency,
has reached a sufficient stage to report results.81  These early results show im-
proved patient medical condition and increased patient satisfaction with the care
received,82 and research indicates that similar home care programs decrease
overall costs.83
At the same time, research shows that women with HIV require more costly
and continuous care than the healthier women who constitute the majority of
TANF program recipients on Medicaid.84  This raises an important issue for
women enrolled in Medicaid managed care plans—access to coordinated care.85
It remains to be seen whether, under the new system, HIV-positive women who
are Medicaid recipients will have access to the full range of services they need,
including care for HIV, opportunistic infections, and related gynecological infec-
tions.86
V.  THE NEW FEDERAL ROLE
The states’ movement to Medicaid managed care is changing the historical
roles of many federal agencies.  In order to be positioned properly to safeguard
vulnerable and underserved populations, the agencies must be responsive to the
realities of the health care market where fee-for-service plans, partially-capitated
managed care plans, and fully-capitated managed plans exist concurrently.87
79. The six projects are funded at the following institutions: the Johns Hopkins University, the
East Boston Neighborhood Health Center, the AIDS Healthcare Foundation, the Visiting Nurses of
Los Angeles, and the New York State AIDS Institute, see BARTLETT & HITZ, supra note 72, at app. C,
and Duke University Medical Center, see SPECIAL PROJECTS OF NATIONAL SIGNIFICANCE (SPNS)
PROGRAM, U.S. DEP’T HEALTH & HUMAN SERVS., PARTNERSHIP STEERING COMMITTEE GRANT PROJECT
ABSTRACTS 8 (1997) [hereinafter GRANT PROJECT ABSTRACTS].
80. See GRANT PROJECT ABSTRACTS, supra note 79, at 2-3.
81. See generally David A. Cherin et al., The Transprofessional Model: Blending Intents in Terminal
Care of AIDS, 17 Q. HOMECARE J. (forthcoming  Mar. 1998) (manuscript on file with the Duke Journal
of Gender Law and Policy).
82. See id. (manuscript at 26-27).
83. See id. (manuscript at 4).
84. See CENTER FOR WOMEN POLICY STUDIES, MEDICAID MANAGED CARE, supra note 7, at 8-9.
85. Cf. Tami Mark & Curt Mueller, Access to Care in HMOs and Traditional Insurance Plans,
HEALTH AFF., Winter 1996, at 81, 82-83 (finding that HMO patients complained of more unmet
health care needs than patients in traditional plans); see also supra notes 58-59 and accompanying
text.
86. See generally AN ACTION PLAN, supra note 33; see also U.S. GEN. ACCOUNTING OFFICE,
MEDICAID: STATES’ EFFORTS TO EDUCATE AND ENROLL BENEFICIARIES IN MANAGED CARE 18-19 (1996);
cf. Shelton et al., supra note 56, at 23.
87. Many federal agencies, including the Centers for Disease Control and Prevention (CDC), the
Food and Drug Administration (FDA), the National Institutes of Health (NIH), the Agency for
Health Care Policy Research (AHCPR), the Health Care Financing Administration (HCFA), and the
Health Resources and Services Administration (HRSA) have been involved with HIV/AIDS since
the beginning of the epidemic in the early 1980s.
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Due to the decentralization of Medicaid, the separation of general public as-
sistance from medical care, and the growth of capitated Medicaid managed care,
the federal government’s role in health care delivery may shift.  Instead of set-
ting rates for fee-for-service reimbursements, the federal government likely will
perform the functions of oversight, enforcement of approved state waivers, and
monitoring of exempt state plans.  Moreover, in order to ensure compatibility
with state Medicaid managed care systems, the federal government will need to
re-examine targeted HIV/AIDS funding streams such as the Ryan White CARE
Act88 and the Centers for Disease Control and Prevention (CDC) prevention co-
operative agreements.89
One challenge facing these agencies involves the use of clinical trials.  The
participation of managed care recipients in clinical trials has become a point of
negotiation and discussion at the NIH and the FDA.90  Clinical trials allow
women with HIV to gain access to new medications, while at the same time
testing the effectiveness of new treatments in women.91  Historically, managed
care networks have sponsored research on the outcomes and effectiveness of
The CDC provides a system of surveillance to monitor and prevent the outbreak of disease, and
supports research into disease and injury prevention.  See Dep’t of Health & Human Servs., DHHS:
What We Do (visited Nov. 15, 1997) <http://www.hhs.gov/about/profile.html>.
The FDA ensures that drugs are safe and effective.  See Food & Drug Admin., Frequently Asked
Questions (visited Feb. 4, 1998) <http://www.fda.gov/opacom/faqs/genfaqs.html>.
The NIH is the world’s premiere research organization; it is involved with 30,000 projects nation-
wide. See Office of AIDS Research, General Information (visited Feb. 4, 1998)
<http://www.nih.gov/od/oar/DSCPFRAM.HTM>.  The NIH has an Office of AIDS Research
(OAR) that is responsible for the scientific, budgetary, legislative, and policy elements of  the NIH’s
AIDS research program.  See id.
The AHCPR is the lead agency in charge of supporting research designed to improve the quality
of health care, reduce its costs, and broaden access.  See Agency for Health Care Policy Research,
About AHCPR (visited Feb. 4, 1998) <http://www.ahcpr.gov/about/about.htm>.
The HCFA is the agency that administers the Medicare and Medicaid programs.  See Health Care
Fin. Admin., What is HCFA? (visited Feb. 4, 1998) <http://www.hcfa.gov/about.htm#whatis>.
With at least 50% of those living with AIDS receiving their health coverage through Medicaid, the
HCFA is the largest single payer of direct medical services for people living with AIDS.  See U.S.
Dep’t of Health & Human Servs., Fact Sheet: Medicaid and Acquired Immune Deficiency Syndrome
(AIDS) and Human Immunodeficiency Virus (HIV) Infection (visited Feb. 4, 1998)
<http://www.hcfa.gov/medicaid/obs11.htm>.
The HRSA provides funding for medically underserved populations.  See U.S. Dep’t of Health &
Human Servs., supra.  It consists of 643 community and migrant health centers and 144 primary care
programs, and serves 8.1 million Americans a year.  See id.  HRSA also provides services to people
with AIDS through the Ryan White CARE Act programs.  See id.
88. See 42 U.S.C. § 300ff-101 (1994), as amended by 42 U.S.C.A. § 300ff-101 (West Supp. 1997).
89. See 42 U.S.C. § 247c (1994); OFFICE OF MANAGEMENT & BUDGET, EXECUTIVE OFFICE OF THE
PRESIDENT, 1997 CATALOGUE OF FEDERAL DOMESTIC ASSISTANCE § 93.940, at 1253-54 (31st ed. 1997).
Through this program, 65 states, localities, and territories receive funds to implement community
HIV prevention programs.  See Helen Schietinger et al., Community Planning for HIV Prevention:
Findings from the First Year, 10 AIDS & PUB. POL’Y J. 140, 140 (1995).
90. See HMO-Based Research Programs Form New Research Network; Lewin-VHI Managed Care Re-
port Released, “The Blue Sheet” (F-D-C Reports, Inc.) 4, 4-5 (Feb. 21, 1996) [hereinafter “The Blue
Sheet”].
91. See generally Anna C. Mastroianni, HIV, Women, and Access to Clinical Trials: Tort Liability and
Lessons from DES, 5 DUKE J. GENDER L. & POL’Y 167, 168-69, 186-91 (1998) (calling for increased en-
rollment of women in clinical trials).
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FDA-approved treatments rather than participating in federally-sponsored clini-
cal research.92
A second challenge that the federal health agencies face concerns the review
and monitoring of state waivers of fee-for-service plans.  While current federal
efforts have focused on initial state waiver review, discussions also are under-
way with respect to ongoing efforts to monitor the states’ progress in imple-
menting Medicaid managed care, including whether states have been able to
maintain access to medical services and to assure appropriate treatments such as
obstetrical care for women with HIV.93  For HRSA in particular, both waiver re-
view and monitoring move the agency beyond its traditional role of funding
health services for vulnerable populations94 to one of assuring the availability of
quality health care.95  While most of the criteria used for waiver review apply to
all individuals living with HIV, some, such as coverage for gynecological care,
are unique to women.96  The review of state waivers and subsequent  monitoring
efforts will require the federal agencies to focus on the quality and accessibility
of HIV/AIDS services by managed care plans, including enrollment procedures
and post-enrollment support, benefit designs, payment systems, patient satisfac-
92. See “The Blue Sheet”, supra note 90, at 5.
93. HCFA and HRSA are holding a series a staff meetings to better coordinate HIV care among
Medicaid and Ryan White CARE Act programs.  See HUMAN RESOURCES & SERVS. ADMIN.,
MANAGED CARE STRATEGIC PLAN: RYAN WHITE CARE ACT PROGRAMS 6 (1997).
94. See HIV CAPITATION RISK ADJUSTMENT, supra note 5, at 65 app. D.
95. See HUMAN RESOURCES & SERVS. ADMIN., STRATEGIC PLAN: 1998-2003 2 (1997) (stating that
the assurance of quality health care is HRSA’s vision for the future).
96. Examples of what is covered in HRSA reviews include:
To what extent will a PCCM [primary care case management] model disrupt provider-
patient relationships, or limit choice of provider and access to experienced HIV care, spe-
cialty care, treatments and services for Medicaid beneficiaries with HIV/AIDS?
. . . .
Are there plans for ongoing meetings between Medicaid staff and the State AIDS Director,
health plan management, medical directors, HIV infected beneficiaries and family mem-
bers, providers, and advocacy groups?  How will these stakeholders participate in the
monitoring of the utilization of HIV services, HIV-related quality of care, and health out-
comes for PLWH [people living with HIV], including asymptomatic HIV-infected benefi-
ciaries?
. . . .
To what extent does the proposal indicate awareness of the incidence and prevalence of
AIDS and HIV-infection among Medicaid beneficiaries within categorical populations?  Is
there recognition that the TANF population may contain substantial numbers of PLWH,
including asymptomatic PLWH, who require early intervention delivered by experienced
HIV-care providers?
. . . .
What additional provisions are to be made during enrollment to assist PLWH who may be
homebound, unable to understand procedures (they may have mental disabilities), or are
not aware of the critical need for responding/or unable to respond in the required time
frames?
HEALTH RESOURCES & SERVS. ADMIN., MEDICAID MANAGED CARE WAIVERS AND POPULATIONS WITH
SPECIAL HEALTH CARE NEEDS: KEY ISSUES OF SPECIAL CONCERN TO PEOPLE LIVING WITH HIV IN-
FECTION (PLWH) 1-5 (draft working paper June 13, 1997) (on file with the Duke Journal of Gender Law
& Policy).
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tion, the quality of clinical care (such as gynecological care for women), and pa-
tient grievance procedures.97
A third challenge that the federal agencies face involves supporting the de-
velopment of new models of HIV/AIDS care to respond to local differences in
populations affected by the epidemic, as well as evaluating differences in state
policies.98  Currently, the SPNS program99 funds the development of six such
capitation models,100 each located in states that applied for, and in some in-
stances, received, section 1115 waivers.101  These programs are investigating risk
adjustment rates for HIV, linkages between health care and appropriate support
services for women, and the integration of health care for mothers and their
children.102
A final challenge for the federal government is the reexamination of its tar-
geted HIV/AIDS funding streams.  When the Ryan White CARE Act103 was for-
mulated, state Medicaid programs were primarily fee-for-service reimbursement
programs.  Most CARE Act funds are distributed by grantees based on service
needs and on a state’s ability to reach underserved populations.  Notices of con-
tract awards by eligible metropolitan areas (EMAs) and by states provide a lump
sum calculated from a line-item organizational budget that includes personnel,
administrative overhead, and contract and/or subcontract dollars.104  Because the
paradigms of health care delivery have changed, this method of allocating funds
will need to be reassessed if the health care providers who receive these funds
participate in Medicaid managed care.  One suggested method for future fund-
ing would link awards to the rate of return on CARE Act “investments” using
health outcome measurements and/or improvements in the quality of life of cli-
ents.105  In addition, direct funding of services for women and children living
97. See OFFICE OF INSPECTOR GEN., DEP’T OF HEALTH & HUMAN SERVS., MEDICAID MANAGED
CARE AND HIV/AIDS (1997) (unpublished draft on file with authors).  At the same time, HCFA has
undertaken a number of monitoring efforts, see James P. Hadley & Linda F. Wolf, Monitoring And
Evaluating the Delivery of Services Under Managed Care, HEALTH CARE FINANCING REV., Summer 1996,
at 1, 1-4, but none is specifically HIV-related, see generally Elizabeth A. McGlynn, Choosing Chronic
Disease Measures for HEDIS: Conceptual Framework and Review of Seven Clinical Areas, in MANAGED
CARE AND CHRONIC ILLNESS: CHALLENGES AND OPPORTUNITIES 18 (Peter D. Fox & Theresa Fama eds.,
1996).
98. See Ryan White CARE Act Amendments of 1996, 42 U.S.C.A. § 300ff-101 (West Supp. 1997).
99. See 42 U.S.C. § 300ff-101; supra text accompanying note 78.
100. See supra note 79 and accompanying text.
101. The most comprehensive and complex model is New York’s section 1115 waiver which,
with the accompanying state legislation, authorizes the creation of Special Needs Plans (SNP) for
Medicaid recipients who are HIV-positive.  Recipients can choose to receive care either from a gen-
eral HMO or from an SNP.  SNPs are HMOs certified by the state to provide comprehensive and
capitated health services to HIV-positive persons eligible for Medicaid.  In return for agreeing to
provide comprehensive HIV care, the HMO becomes eligible for risk-adjusted reimbursement.  See
New York Health Care Reform Act of 1996, N.Y. PUB. HEALTH LAW § 2807-f (McKinney Supp. 1997-
1998).  For further information on section 1115 waivers, see discussion supra notes 25-30 and accom-
panying text.
102. See generally HIV CAPITATION RISK ADJUSTMENT, supra note 5.
103. See 42 U.S.C. § 300ff-101 (1994).
104. See WALTER MOREAU, U.S. DEP’T. OF HEALTH & HUMAN SERVS., TOOLS AND STRATEGIES TO
ASSURE THE COST AND OUTCOME EFFECTIVENESS OF CARE ACT SERVICES 34 (1997).
105. See id. at 6.
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with HIV/AIDS may need to be reconfigured based upon the services and
populations covered by Medicaid managed care.
VI.  CONCLUSION
The paradigm shift from fee-for-service to managed care encompasses
many changes, including changes in emphasis from acute, episodic interventions
to preventive care, changes in access to care for the populations to whom care is
delivered, and changes in the cost reimbursement mechanisms.  While some spe-
cific aspects of the paradigm shift, such as the coverage of pharmaceuticals, are
important to all individuals living with HIV/AIDS, others, such as the access of
TANF recipients to specialty care and children’s health care, particularly are sig-
nificant for women given women’s complex care and treatment needs.  Further-
more, the supportive services that would be included in a comprehensive con-
tinuum of care, which traditionally may not have been viewed as included in
health care, such as the provision of housing, or follow-up after substance abuse
treatment, must be provided if medical treatment is to be effective.
The complexity of the new Medicaid managed care plans and the differ-
ences among states in eligibility and coverage make the federal health agencies’
monitoring of states’ coverage of HIV/AIDS care critical.  In order for Medicaid
managed HIV/AIDS care to benefit women, and especially for women of color,
federal agencies and providers of HIV/AIDS care will have to collaborate to en-
sure that each state’s plan is able to deliver affordable, accessible, and quality
care.  Otherwise, notwithstanding the opportunities afforded by the paradigm
shift, cost containment principles will be achieved at the expense of individuals’
health care.
